Transcirculation approach for stent-assisted coiling of intracranial aneurysms: a multicenter study.


Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 20 09 2020
revised: 27 10 2020
accepted: 02 11 2020
pubmed: 19 11 2020
medline: 27 7 2021
entrez: 18 11 2020
Statut: ppublish

Résumé

The transcirculation approach (TCA) for stent-assisted coiling (SAC) of intracranial aneurysms may be useful for certain wide-neck bifurcation aneurysms as well as those with acute-angle efferent branches. To describe a multicenter experience using the TCA for SAC. A multicenter, retrospective study (2016-2020) of aneurysm treatment using SAC via the TCA. Angiographic outcome was scored using the Raymond Scale (adequate occlusion 1 and 2), and clinical outcome was scored using a modified Rankin Scale (good outcome 0-2) RESULTS: Twenty-nine patients with 29 aneurysms were included (62.1% female; average age 61; 89.7% unruptured; 13.8% previously treated; average dome size 6.4 mm; average neck 4.4 mm). Aneurysm locations included internal carotid artery-fetal posterior cerebral artery (n=4), internal carotid artery terminus (n=4), anterior communicating artery (n=8), vertebral artery-posterior inferior cerebellar artery (n=2), and basilar tip (n=11). The TCA used communicating arteries (93.1%; average 1.6 mm), intermediate catheters (51.7%), jailing technique (62.1%), and staged procedures (10.3%). The most common stent was the Neuroform Atlas (Stryker; 69%). Immediate adequate occlusion was obtained in 75.9%, and five patients with inadequate occlusion progressed to adequate occlusion at follow-up. One (3.4%) procedural complication occurred: a watershed stroke in the setting of baseline four-vessel extracranial disease. Two patients had a poor outcome unrelated to the TCA. The majority of patients (86.4%) had a good clinical outcome. One case of in-stent stenosis due to non-compliance with medication was seen, which resolved with medication resumption. The TCA for SAC can be performed for a variety of aneurysms with a low complication rate and good clinical outcomes.

Sections du résumé

BACKGROUND BACKGROUND
The transcirculation approach (TCA) for stent-assisted coiling (SAC) of intracranial aneurysms may be useful for certain wide-neck bifurcation aneurysms as well as those with acute-angle efferent branches.
OBJECTIVE OBJECTIVE
To describe a multicenter experience using the TCA for SAC.
METHODS METHODS
A multicenter, retrospective study (2016-2020) of aneurysm treatment using SAC via the TCA. Angiographic outcome was scored using the Raymond Scale (adequate occlusion 1 and 2), and clinical outcome was scored using a modified Rankin Scale (good outcome 0-2) RESULTS: Twenty-nine patients with 29 aneurysms were included (62.1% female; average age 61; 89.7% unruptured; 13.8% previously treated; average dome size 6.4 mm; average neck 4.4 mm). Aneurysm locations included internal carotid artery-fetal posterior cerebral artery (n=4), internal carotid artery terminus (n=4), anterior communicating artery (n=8), vertebral artery-posterior inferior cerebellar artery (n=2), and basilar tip (n=11). The TCA used communicating arteries (93.1%; average 1.6 mm), intermediate catheters (51.7%), jailing technique (62.1%), and staged procedures (10.3%). The most common stent was the Neuroform Atlas (Stryker; 69%). Immediate adequate occlusion was obtained in 75.9%, and five patients with inadequate occlusion progressed to adequate occlusion at follow-up. One (3.4%) procedural complication occurred: a watershed stroke in the setting of baseline four-vessel extracranial disease. Two patients had a poor outcome unrelated to the TCA. The majority of patients (86.4%) had a good clinical outcome. One case of in-stent stenosis due to non-compliance with medication was seen, which resolved with medication resumption.
CONCLUSIONS CONCLUSIONS
The TCA for SAC can be performed for a variety of aneurysms with a low complication rate and good clinical outcomes.

Identifiants

pubmed: 33203763
pii: neurintsurg-2020-016899
doi: 10.1136/neurintsurg-2020-016899
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

711-715

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: JRM: Compensated for lectures for Penumbra and PMI. MRL: Educational grants from Stryke, Medtronic, Philips volcano; equity interest in Synchron, Cerebrotech, Eloupes; adviser for Metis Innovative; consultant for Medtronic. CJG: Consultant to Stryker; research funding from Medtronic. LJK: Stock ownership, Spi Surgical, LLC. BG: Consultant for Medtronic and MicroVention. AA: Consultant for Stryker. BJ: Consultant for Stryker, Medtronic. RG: Consultant to BALT Neurovascular, Medtronic, Cerenovus. CMS: Research support: Penumbra; ownership; Neurotechnology investors.

Auteurs

Justin R Mascitelli (JR)

Department of Neurosurgery, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA jmascite@gmail.com.

Michael R Levitt (MR)

Department of Neurosurgery, University of Washington School of Medicine, Seattle, WA, USA.

Christoph J Griessenauer (CJ)

Department of Neurosurgery, Geisinger Health System, Danville, PA, USA.
Research Institute of Neurointervention, Paracelsus Medical University, Salzburg, Austria.

Louis J Kim (LJ)

Department of Neurosurgery, University of Washington School of Medicine, Seattle, WA, USA.

Bradley Gross (B)

Department of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Adib Abla (A)

Department of Neurosurgery, University of California, San Francisco, San Francisco, CA, USA.

Ethan Winkler (E)

Department of Neurosurgery, University of California, San Francisco, San Francisco, CA, USA.

Brian Jankowitz (B)

Department of Neurosurgery, Cooper University Health Care, Camden, NJ, USA.

Ramesh Grandhi (R)

Department of Neurosurgery, University of Utah, Salt Lake City, UT, USA.

Oded Goren (O)

Department of Neurosurgery, Geisinger Health System, Danville, PA, USA.

Clemens M Schirmer (CM)

Department of Neurosurgery, Geisinger Health System, Danville, PA, USA.
Research Institute of Neurointervention, Paracelsus Medical University, Salzburg, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH